Published April 1, 2021
| Version v1
Patent
Open
COMPOSITIONS AND METHODS FOR INHIBITION OF FOXP3
Creators
- 1. University of Chicago
- 2. Dana-Farber Cancer Institute
Contributors
Patent applicants:
Patent assignee:
Description
Provided herein are peptide-based therapeutics that target FOXP3 and methods of use thereof to decrease the immunosuppressive effects of Tregs and inhibit immune dysregulation, while sparring inhibition of activated cytotoxic T cells, for example, in the context of anti-tumor immune responses, autoimmunity, inflammatory conditions, etc.
Files
US20210094990.pdf
Files
(3.2 MB)
| Name | Size | Download all |
|---|---|---|
|
md5:d6463bff7bdc8680dd0b361872636297
|
3.2 MB | Preview Download |
Additional details
Identifiers
- Patent application number
- US 201716464590 A
- Patent number
- US 2021/0094990 A1
- Other
- oai:uchicago.tind.io:9478
Dates
- Patent filed
-
2017-12-07